about
The significance of genetics for cholangiocarcinoma developmentThe BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cellsDeregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential BiomarkersMicroRNA-26a promotes cholangiocarcinoma growth by activating β-cateninCrucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agentsUpdate on the Diagnosis and Treatment of Cholangiocarcinoma.Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis.Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells.Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating KRAS Mutation.Primary Cilia in Tumor Biology: The Primary Cilium as a Therapeutic Target in Cholangiocarcinoma.Extracellular vesicle noncoding RNA: new players in the diagnosis and pathogenesis of cholangiocarcinomaHistological classification of liver and intrahepatic bile duct cancers in SEER registries.Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.Clonorchis sinensis infestation promotes three-dimensional aggregation and invasion of cholangiocarcinoma cellsOver-expression of nerve growth factor-β in human cholangiocarcinoma QBC939 cells promote tumor progression.Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growthComparison between uncovered and covered self-expandable metal stent placement in malignant duodenal obstruction.Phenethyl isothiocyanate induces calcium mobilization and mitochondrial cell death pathway in cholangiocarcinoma KKU-M214 cells.Novel pH-sensitive nanoformulated docetaxel as a potential therapeutic strategy for the treatment of cholangiocarcinoma.Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.Molecular diagnosis of intrahepatic cholangiocarcinoma.The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.Cell-SELEX based selection and optimization of DNA aptamers for specific recognition of human cholangiocarcinoma QBC-939 cells.Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma.Prognostic significance of microRNA-203 in cholangiocarcinoma.Activation or suppression of the immune response mediators in biliary tract cancer (BTC) patients: a systematic review and meta-analysisMandibular metastasis of cholangiocarcinoma: A case reportCharacterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma developmentMajor histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer.Annexin A1: A new immunohistological marker of cholangiocarcinoma.Delivery of miR-200c Mimic with Poly(amido amine) CXCR4 Antagonists for Combined Inhibition of Cholangiocarcinoma Cell Invasiveness.A long survivor with local relapse of hilar cholangiocarcinoma after R1 surgery treated with chemoradiotherapy: a case report and literature review.Impact of medical and surgical intervention on survival in patients with cholangiocarcinomaThe Preoperative Assessment of Hepatic Tumours: Evaluation of UK Regional Multidisciplinary Team Performance.Preneoplastic conditions underlying bile duct cancer.Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.
P2860
Q26865749-0B15AE17-50EE-47C3-8E4B-EAAA0D03706CQ27340125-3942792A-30DA-4FB6-986D-6670B493C54FQ28073195-1EF8720D-2F80-4208-BD38-D282FF767B64Q28263940-8CF711A4-C0B5-4270-8F98-E79DC250B158Q28482275-D421F19F-18A9-4F1C-9858-D53637FE36BAQ30238895-EDDEB640-D8A7-4EFF-A268-E781C978468EQ30585821-D7F01889-4480-4657-B728-67F28EB3C652Q33751337-CE476D5B-7EC7-40E2-B20C-731674A94B5BQ33757122-ACB0154E-A420-400B-96B6-93AF0BF29B0DQ33758343-9208EF17-A884-4655-B46A-D0422D11ED47Q33775133-285B1E5B-97D7-4066-AE32-61AFC0A21C16Q33894574-C5B5DF3E-9C0C-4850-949B-AF2058622567Q34098435-B5D29151-CDD4-480C-BAAF-01430DAC9D9CQ34103576-52CBBA9E-9D47-4DA3-94B0-51BC0AEA92A4Q34200081-54E8D696-CE77-4A4B-8FDE-1DA18A106B6EQ34395425-713AF52A-B2FE-404A-8DD7-CE1615083279Q34700856-C6F17E4B-CA00-44CB-A7BA-25927172A59AQ34811043-D45E42D1-D68A-460A-8248-F47D2737C8FDQ35045779-ECD94CEA-680E-44C8-846D-F1FEFBA949DAQ35058902-F1C8834A-D769-4EB0-894D-C106E46A1B90Q35151608-A21CC4F0-DE52-4396-9DD9-BFEA761BA5AEQ35166443-B6999140-9FF8-4EF3-AEBF-2BCA60D14095Q35251736-B0DDFE9D-8663-43B7-B420-5659AB88C142Q35592221-2F5438D6-3C00-4779-8338-7E33F4390099Q35671261-CCA999DF-A095-4810-8CC8-014B6D5F83B1Q35693567-046743CF-18B0-4EC7-B7F7-88B25DF1432CQ35892542-CBE66D51-21FB-4964-A0AB-937F9C9BD1F5Q35956062-5276533C-7C00-49D3-9800-BE96345760B0Q36095393-6A73E434-8A3A-4FBD-8D6B-AAC9011AE6EBQ36260577-9597E111-BAC6-4589-BE79-8338B80F682FQ36418873-63AFA01B-6C8B-44DD-B950-C3020E280A69Q36611934-1F663FFB-C0DC-4EAD-B3DA-AD9D7BC86332Q36750601-F9CDA97B-7B81-4D12-B980-378CC931ED1BQ36821610-34D8B208-3992-4A5F-A177-A4B491EC039AQ37045471-25AC2708-C6F4-44C5-9AD1-825040F6E799Q37062864-6B0E82C1-5A73-4CE1-B03A-1FEC50CCDFBDQ37112614-452AE4AB-E51F-4D1D-A83D-5A1CF44B59EEQ37154790-2D4400B4-1D41-4B85-92FF-F065775F2A19Q37246190-6FABDEFE-FED5-4B98-9066-1008095BEE0EQ37246194-C613D002-C150-4CD7-845B-1A5E08CD9B67
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cholangiocarcinoma--controversies and challenges.
@en
Cholangiocarcinoma--controversies and challenges.
@nl
type
label
Cholangiocarcinoma--controversies and challenges.
@en
Cholangiocarcinoma--controversies and challenges.
@nl
prefLabel
Cholangiocarcinoma--controversies and challenges.
@en
Cholangiocarcinoma--controversies and challenges.
@nl
P2860
P356
P1476
Cholangiocarcinoma--controversies and challenges.
@en
P2093
Tushar Patel
P2860
P2888
P304
P356
10.1038/NRGASTRO.2011.20
P407
P577
2011-04-01T00:00:00Z